Literature DB >> 25917313

Defining, Treating, and Understanding Chronic Kidney Disease--A Complex Disorder.

Dean Campbell1, Matthew R Weir2.   

Abstract

Chronic kidney disease (CKD) is prevalent in more than 20 million people in the United States. The majority of care provided to patients with this disease comes from primary care physicians, although it is often poorly understood. After an extensive literature review, it is clear that it can be difficult to classify and there are many barriers to care. Risk factors for both incident CKD and disease progression include hypertension, poor glycemic control, sociodemographic factors, acute kidney injury, metabolic acidosis, and possibly hyperuricemia and dietary factors. Treatment of patients with CKD should focus on mitigating risk factors, as well as common comorbidities such as cardiovascular disease, anemia, and bone mineral disease. Novel therapies such as pirfenidone, pentoxifylline, and endothelin-1 antagonists are being investigated with promising results.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25917313      PMCID: PMC8031501          DOI: 10.1111/jch.12560

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  81 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  Groups spar over new hypertension guidelines.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

3.  Sitagliptin--another option for managing type 2 diabetes in dialysis patients?

Authors:  Wendy L St Peter; Eric D Weinhandl; Michael F Flessner
Journal:  Am J Kidney Dis       Date:  2013-04       Impact factor: 8.860

4.  Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.

Authors:  Donald E Kohan; Yili Pritchett; Mark Molitch; Shihua Wen; Tushar Garimella; Paul Audhya; Dennis L Andress
Journal:  J Am Soc Nephrol       Date:  2011-03-03       Impact factor: 10.121

5.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

Authors:  Andrew S Levey; Paul E de Jong; Josef Coresh; Meguid El Nahas; Brad C Astor; Kunihiro Matsushita; Ron T Gansevoort; Bertram L Kasiske; Kai-Uwe Eckardt
Journal:  Kidney Int       Date:  2010-12-08       Impact factor: 10.612

7.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

8.  Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.

Authors:  Mark E Molitch; Michael Steffes; Wanjie Sun; Brandy Rutledge; Patricia Cleary; Ian H de Boer; Bernard Zinman; John Lachin
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 19.112

9.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

Review 10.  Chronic kidney disease in United States Hispanics: a growing public health problem.

Authors:  Claudia M Lora; Martha L Daviglus; John W Kusek; Anna Porter; Ana C Ricardo; Alan S Go; James P Lash
Journal:  Ethn Dis       Date:  2009       Impact factor: 1.847

View more
  9 in total

1.  The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure.

Authors:  Hongtao Hu; Shen Xu; Shuang Hu; Weijia Xu; Hua Shui
Journal:  Exp Ther Med       Date:  2017-06-08       Impact factor: 2.447

2.  Rotenone ameliorates chronic renal injury caused by acute ischemia/reperfusion.

Authors:  Wen Zhang; Yugen Sha; Ke Wei; Chunfeng Wu; Dan Ding; Yunwen Yang; Chunhua Zhu; Yue Zhang; Guixia Ding; Aihua Zhang; Zhanjun Jia; Songming Huang
Journal:  Oncotarget       Date:  2018-05-11

3.  Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study.

Authors:  Irene Ma; Maggie Guo; Daniel Muruve; Hallgrimur Benediktsson; Christopher Naugler
Journal:  BMC Nephrol       Date:  2018-08-09       Impact factor: 2.388

4.  Association of Serum Thyroid Hormones with the Risk and Severity of Chronic Kidney Disease Among 3563 Chinese Adults.

Authors:  Jialin Li; Xi'ai Wu; Minjing Luo; Meihua Yan; Qian Wang; Ping Li; Wenquan Niu
Journal:  Med Sci Monit       Date:  2020-06-22

5.  Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury.

Authors:  Lies Moonen; Hilde Geryl; Patrick C D'Haese; Benjamin A Vervaet
Journal:  BMC Nephrol       Date:  2018-12-03       Impact factor: 2.388

Review 6.  Defining, Treating, and Understanding Chronic Kidney Disease--A Complex Disorder.

Authors:  Dean Campbell; Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-27       Impact factor: 3.738

7.  Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice.

Authors:  Nathalie Le Clef; Anja Verhulst; Patrick C D'Haese; Benjamin A Vervaet
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

8.  PEGylated pUR4/FUD peptide inhibitor of fibronectin fibrillogenesis decreases fibrosis in murine Unilateral Ureteral Obstruction model of kidney disease.

Authors:  Bianca R Tomasini-Johansson; Pawel W Zbyszynski; Inger Toraason; Donna M Peters; Glen S Kwon
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

9.  Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data.

Authors:  Heleen van Haalen; James Jackson; Bruce Spinowitz; Gary Milligan; Rebecca Moon
Journal:  BMC Nephrol       Date:  2020-03-07       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.